Southern Europe New Drug Organization

Quick facts

Phase 2 pipeline

• LBH581 · Immunology
  LBH581 is a small molecule inhibitor of the PI3K delta and PI3K gamma enzymes.

Phase 1 pipeline

• RAD 001 in combination with Caelyx
• Satraplatin in combo with vinorelbine

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Southern Europe New Drug Organization portfolio CI brief
• Southern Europe New Drug Organization pipeline updates RSS

Related

• Sector hub: All tracked pharma companies